
Atek Bio
阿泰克生物
Atek Bio
Biotech/Healthcare
Atec focuses on developing globally novel, next-generation protein degradation drugs. The company is pursuing a differentiated approach centered on small-molecule glue drugs that induce targeted degradation through the autophagy-lysosome pathway, with the aim of providing new treatments for…
Latest round: Series B (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-10-30
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.